37 results
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
Osteoporosis Treatment ... Algorithm Evaluate ... address causes ... • Recommend pharmacologic ... risks of medications
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
formulations, comparison and ... considerations #pharmacology ... #table #medications ... comparison #drugs #treatment ... pharmacotherapy #dermatology
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
of Weight-Loss Medications ... the long-term treatment ... mg #Obesity #Medications ... WeightLoss #AACE #2016 ... #Pharmacology #
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... #pharmacology # ... treatment #medications ... decisionaid #cardiology #hematology
Initial triage of the neutropenic adult - Algorithm for the evaluation and treatment of adult patients
neutropenic adult - Algorithm ... the evaluation and ... treatment of adult ... workup #diagnosis #hematology ... #biopsy #indications
A quick infographic describing some of the common reversal agents used by anesthesiologists, their mechanism of
anesthesiology #treatment ... #medications ... amp; Mishra, R. (2015 ... Pharmacology of ... neuromuscular pharmacology
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Tranexamic Acid - Indications ... and Pharmacology ... Tranexamic #Acid #Indications ... #Pharmacology # ... hematology
Eosinophil Disorders Testing Algorithm
INDICATIONS FOR TESTING:
 • Peripheral blood eosinophilia/hypereosinophilia uncovered incidentally during medical evaluation or
Disorders Testing Algorithm ... INDICATIONS FOR ... for secondary causes ... eosinophilia (common causes ... glucocorticoid treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... recommendations for the treatment ... the use of this medication ... #Roflumilast #Indications ... #Pharmacology #
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
Dermatitis - Topical Treatment ... 20% of children and ... After non-pharmacologic ... #Medications #Pharmacology ... #Dermatology #Management